Neogenomics (NEO) Gains from Investment Securities (2010 - 2025)
Neogenomics (NEO) posted Gains from Investment Securities of $5.9 million for Q4 2025, up 1196.72% quarter-over-quarter from $458000.0 in Q2 2025, and up 1892.95% year-on-year from $298000.0 in Q4 2024.
Neogenomics (NEO) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Neogenomics (NEO) has reported Gains from Investment Securities for 16 consecutive years, with $5.9 million the latest figure, recorded in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $5.9 million, up 1892.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 1111.55% YoY), and the FY2025 annual result was $6.4 million, up 936.79% from the prior year.
- Gains from Investment Securities was $5.9 million for Q4 2025 at Neogenomics, up from $458000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $7.3 million in Q4 2023 and troughed at -$49000.0 in Q1 2021.
- Average Gains from Investment Securities over 5 years is $990800.0, with a median of $129000.0 recorded in 2022.
- Year-over-year, Gains from Investment Securities slumped 2550.0% in 2021 and jumped 29280.0% in 2023.
- Over 5 years, Gains from Investment Securities stood at $35000.0 in 2021, then dropped by 28.57% to $25000.0 in 2022, then surged by 29280.0% to $7.3 million in 2023, then slumped by 95.94% to $298000.0 in 2024, then soared by 1892.95% to $5.9 million in 2025.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $5.9 million in Q4 2025, $458000.0 in Q2 2025, and $298000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.94 Mn |
| Dec 31, 2025 | 5.94 Mn |
| Jun 30, 2025 | 458,000.00 |
| Jun 30, 2025 | 458,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 7.35 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Jun 30, 2023 | 175,000.00 |
| Jun 30, 2023 | 175,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |